Gala Health vs Hone Health
Side-by-side HRT telehealth comparison · Verified August 16, 2026
The short answer
Too close to call on score alone: Gala Health 7.2 vs Hone Health 7.5, inside our 0.3-point tie margin. The verdict depends on which buyer you are: for compounded menopause HRT on one flat plan covering every format, billed every 12 weeks, pick Gala Health (from $86/mo (~$892 realistic first year)); for labs-first hormone care for both partners: biomarkers before prescriptions, pick Hone Health (from $25/mo (~$700 realistic first year)).
| Gala Health | Hone Health | |
|---|---|---|
| Score | 7.2/10 | 7.5/10 |
| Transparency grade | C | C |
| Consult fee | No membership fee and no separate consult fee. The plan price covers clinician care, messaging and shipping [Verified August 2026] | $65 initial Biomarker Test + Consult [Verified July 2026] |
| Monthly cost | From $86/mo | From $25/mo |
| Real first-year cost | ~$892 | ~$700 |
| Bloodwork | Not surfaced; lab-work requirement not disclosed on the pages we could reach [Reported] | 50+ biomarker panel required to start ($65 with consult); retesting every 90 days (Premium) or 6 months (Basic) [Verified July 2026] |
| Formats offered | oral, patch, vaginal | injection, cream, oral, patch |
| Insurance | No, cash pay | No, cash pay |
| States | Available across most US states, per Gala's own wording. It publishes no list and confirms eligibility inside the assessment. The 'all 50 states' figure on the site belongs to the GLP-1 line, not HRT [Verified August 2026] | US, varies by state; no public state list [Reported] |
| Trustpilot | Not surfaced | 4.8/5 · ~12,069 reviews |
| Visit Gala Health | Visit Hone Health |
Gala Health first-year math: The plan bills $237 every 12 weeks, and the first cycle is $99 with code GALA138. Eighty-four days per cycle means a 365-day year holds 4.345 of them, so year one is $99 + 3.345 cycles at $237 = $891.76, cash-pay with free shipping included. Without the intro code the same year is $1,029.82, which is $85.82 a month, not the $79 Gala advertises. One flat plan covers whichever format is prescribed, so there is no per-format upcharge to add [Verified August 2026].
Hone Health first-year math: Floor estimate: $65 assessment + Basic $25/mo × 12 ($300) + cheapest testosterone injections $28/mo × 12 ($336) ≈ $700. Premium tier: $65 + $155 × 12 + meds ≈ $2,200+.
Choose Gala Health if
Women who want compounded menopause HRT with a price they can see up front, free shipping and included messaging, who are fine with one plan covering whichever format they end up on, and who accept unnamed clinicians and a compounded (non-FDA-approved) formulary.
From $86/mo · Transparency C
Read full Gala Health review →Choose Hone Health if
Data-driven patients (or couples) who want 50+ biomarkers tracked on a schedule and are comfortable doing membership-plus-medication math.
From $25/mo · Transparency C
Read full Hone Health review →Where both fall short
The honest part
Gala Health
- Compounded (non-FDA-approved) status not clearly disclosed on Gala's own funnel [Verified July 2026]
- No named clinicians, 'licensed clinicians' only [Reported]
- Manufactured-reputation pattern: paid 'Gala Health HRT Review 2026' PR on Newswire + 'Under Investigation' clickbait on GlobeNewswire/Yahoo; self-cited ratings are not independently verified [Verified July 2026, press pattern]
- Trustpilot base is platform-wide (GLP-1 + HRT), not menopause-specific [Reported]
- Bills every 12 weeks while advertising a monthly price, and its own conversion understates the true monthly rate by $6.82 [Verified August 2026]
Hone Health
- The advertised $25/mo is a membership fee, not a treatment price. Budget $53-$180+/mo all-in
- PR-placed 'review' articles on Newswire [Reported]
Go deeper
This is general information, not medical advice. Hormone therapy is prescription treatment. Whether either provider fits your health history is a decision for a licensed clinician. Facts on this page render from our provider data layer, verified August 16, 2026 where sites allow crawling; items marked [Reported] rest on third-party sources.